Breaking News

Societal CDMO Inks Manufacturing and Packaging Agreement with NCI

Contract is for the manufacture and packaging of ammonium tetrathiomolibdate capsules to support clinical development of the compound.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Societal CDMO, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, has been awarded a new manufacturing and packaging task order agreement by the National Cancer Institute’s Division of Cancer Treatment and Diagnosis (DCTD). The new contract is an individual task order of more than $400,000 for the manufacture and packaging of ammonium tetrathiomolibdate (ATTM) caps...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters